pharma news today glp-1 today Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 News Roundup: 10 Massive
Description
Novo Nordisk announced that its rebranded and reformulated oral GLP-1 medication, formerly known as Rybelsus, is now available in the U.S
Results The search strategy identified 833 hits, of which 42 studies were included in the final review
To date, the protective cardiovascular effects of these drugs in patients with and without T2D are not completely understood and several mechanisms have been proposed
New Benefits Canada report reveals GLP-1 medications are a major driver of employer drug plan cost increases in 2026 despite expected generic approvals.
That is what is getting attention with the latest Retatrutide data
You receive a complete VIP membership operating system with templates, print friendly versions, and a tracker, grouped by purpose
